NASONEX Allergy Non-Drowsy 24 Hour Nasal Spray Twin Pack 2 x 140 Sprays
$52.95 $42.95
Nasonex Allergy Nasal Spray is an effective treatment & prevention of hayfever, dust allergies, pet allergies & mould allergies. Nasonex Allergy is a once a day nasal spray which offers powerful treatment and prevention of tough hayfever symptoms without a prescription, helping to relieve you from the frustration and exhaustion that hayfever can bring.
Out of stock
Ingredients
Mometasone furoate 50 micrograms/spray.
Directions
The pump should be primed prior to first use or if it has not been used for 14 days or longer. Shake well before each use. Adults and children 12 years and over: Initially 2 sprays into each nostril once daily. Once symptoms are controlled, reduce to 1 spray into each nostril once daily. Maximum daily dose: One dose in 24 hours. Use every day for best results. It may take 1-2 days for the full effect to take place. Do not exceed the maximum daily dose. Please read the leaflet enclosed in the carton before use, and for full priming, spraying and cleaning instructions.
Caution
Do not use this product: In children under 12 years of age. Continuously for more than 6 months without the advice of your doctor or pharmacist. If you have severe nose infection. Consult your doctor or pharmacist if: Your symptoms are not relieved within 7 days. Your nose bleeds. You develop signs of a nasal or sinus infection such as fever, pain or swelling or discoloured nasal discharge. You have eye pain or visual disturbances. Consult your doctor or pharmacist before use if you: Have a history of tuberculosis. Have infection of the nose or sinus. Have ulceration in the nose or have recently had an injury or surgery to your nose. Are pregnant or breastfeeding or are planning to become pregnant or breastfeed. Contains benzalkonium chloride as preservative. For Intranasal use only. Do not use if the seal on carton is broken or missing.
Only logged in customers who have purchased this product may leave a review.
Reviews
There are no reviews yet.